A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention

Published:2024-09-11 Issue: Volume: Page:
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Cella Arianna¹,Marè Alessandro¹,Gigli Gian Luigi²,Zedde Marialuisa³,Valente Mariarosaria¹²,Merlino Giovanni¹⁴^ORCID

Affiliation:

1. Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy

2. DMED, University of Udine, Udine, Italy

3. Neurology Unit, Department of Neuromotor Physiology and Rehabilitation, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

4. Stroke Unit, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2024.2402496

Reference55 articles.

1. Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association;Kleindorfer D. O.;Stroke,2021

2. Adelaide Stroke Incidence Study

3. Pharmacology and Clinical Development of Factor XI Inhibitors

4. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

5. News at XI: moving beyond factor Xa inhibitors;Fredenburgh J. C.;Journal of Thrombosis and Haemostasis,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP